#CreativeDisruption: Latest & Future Technologies Impacting Life Sciences
This thought-leader discussion is about technologies that are disrupting the life sciences and health innovation sectors today & tomorrow
About the Event
The Creative Disruption Forum is a high-level, interactive gathering built for executive leaders, senior researchers, startup founders, and biotech investors.
The Quantum Horizon Meets Real-World Science
We are witnessing a transformative shift in health innovation. While emerging paradigms like quantum computing promise to fundamentally redefine how we process biological complexity in the future, biopharma leaders today need actionable, deployable technologies to de-risk pipelines, accelerate drug discovery, and improve clinical outcomes now.
The Latest & Future Technologies Impacting Health Innovation and Life Sciences bridges the gap between tomorrow’s deep-tech horizons and today’s high-impact biological and computational breakthroughs. Hosted at ARC West London as a flagship London Life Sciences Week event, this interactive forum brings together biopharma executives, tech bio founders, investors, and academic leaders for unscripted, Chatham House Rules discussions on what is genuinely working, where the bottlenecks lie, and how to build scalable healthcare solutions.
From physical molecule-to-protein target engagement (such as CETSA® platforms) and human-relevant New Approach Methodologies (NAMs) to real-world AI applications in lead optimization, this event delivers an unfiltered "boots on the ground" look at modern translational science.
Why You Should Attend:
Ground Your Strategy in Real-World Tech: Move beyond theoretical hype to evaluate proven technologies transforming R&D pipelines today—including next-gen sequencing (NGS), advanced cell & gene therapies, and biophysical target-engagement assays.
De-Risk Your Clinical Pipeline: Discover how New Approach Methodologies (NAMs), organ-on-a-chip systems, and cellular shift assays are replacing legacy models, reducing Phase II/III failure rates, and delivering more efficacious molecules into the clinic.
Unfiltered "Boots on the Ground" Insights: Hear directly from SME CEOs and biopharma R&D directors on integrating AI into discovery pipelines—sharing candid case studies on what works, what has failed, and how to avoid costly missteps.
Connect Across the West Tech District: Engage directly with key anchors across West London’s innovation ecosystem, including Imperial College London, White City Innovation District, Paddington Life Sciences, Nexus, and ARC Group.
Actionable Peer-to-Peer Workshops: Participate in interactive afternoon breakout sessions designed to co-create practical strategies for scaling deep-tech venture navigating regulatory pathways for NAMs, and optimizing R&D data.
Who Should Attend:
- Biopharma & Biotech Executives (CEOs, CSOs, CTOs, R&D Directors): Looking to de-risk discovery pipelines, adopt next-generation analytical platforms, and integrate computational tools effectively.
- Tech Bio Founders & SME Leadership: Seeking real-world feedback on scaling ventures, securing investment, and overcoming wet-lab validation bottlenecks.
- Venture Capitalists & Deep-Tech Investors: Eager to identify high-growth opportunities across both near-term biopharma technologies and long-term deep-tech frontiers.
- Academic Researchers & Translational Scientists: Interested in commercializing spinouts and bridging the gap between basic research and clinical reality.
- Clinical & Regulatory Leaders: Exploring FDA/MHRA roadmaps for NAM adoption, advanced diagnostics, and cell/gene therapy pathways.
Agenda
09:00 AM – 09:45 AM | Registration, Breakfast & Networking
Arrival, registration, and informal networking over breakfast.
09:45 AM – 10:00 AM | Welcome and sponsor thank yous
- Welcome: Deb Spencer (ARC West London)
- Opening Address: Prof Tony Sedgwick & Graham Combe
Draft Agenda
09:00 AM – 09:45 AM | Registration, Breakfast & Networking
Arrival, registration, and informal networking over breakfast.
09:45 AM – 10:00 AM | Welcome and sponsor thank yous
- Welcome: Deb Spencer (ARC West London)
- Opening Address: Prof Tony Sedgwick & Graham Combe
10:00 AM – 10:45 AM | Opening Keynote Panel: The Future Promise of Quantum & Deep Tech in Healthcare
· Adam Hammond, Head of Quantum EMEA, IBM
· Anshu Bansal, Imperial College and London Quantum Cluster
· Sonali Mohapatra, National Quantum Computing Centre.
· James Fry, Mills & Reeve
10.45 AM - 11.30 am : De-Risking Pipelines — Target Engagement & New Approach Methodologies (NAMs) and Biomarker Strategies
Unpacking intracellular target engagement in live cells (e.g., CETSA® and biophysical mass spectrometry) alongside microphysiological systems (organ-on-a-chip, 3D organoids) to confirm compound binding and improve translational success before clinical entry. What are the biomarkers we need to look for to find efficacy?
Michael Dabrowski, CEO, Pelago Bioscience AB
Pelin Candorlioglu, 3 D and 3Rs
Michelle Barnard, Valirx plc
Sharon Robinson, DLRC Regulatory Consulting
Prof Christopher Peters, Imperial College
Atefeh Mobasseri, CN Bio
11:30 PM – 12:00 PM | Refreshments & Networking Break
12:00 PM – 12:30 PM | Considerations with IP when using new technologies
Emily Howard, J A Kemp
Flick Kendrick, JA Kemp
12:30 PM – 1.00 PM | Fireside Keynote Interview with Edwin Moses, Chairman, LabGenius, Avantium AV and Nanosyrinx.
1:00 PM – 1:45 PM | Keynote Panel: What’s working so far with AI, and what’s not?
Jeremy Reffin, AI Research Group, University of Sussex
Steve Lindsay, SFL Technology
Juergen Harter, MatriQx
Catherine Stace, O2h Group
Ting Qin, Sygnature Discovery
01:45 PM – 02:45 PM | Networking Lunch
02:45 PM – 03:30 PM | Boots on the Ground – hearing from emerging company leaders about the technologies changing their work
Winston Hayes, LabGenius
Paul Rouse, IMU Biosciences
Chris Tame, Ternary Tx
Hugh O’Brien, LIR Tx
Andrea Dimitracopoulos, Deep Mirror
03:30 PM – 04:10 PM | What are the major early considerations when translating and innovation from promise to idea?
Mariana Vashetto, CDD Vault
Luis Lopez-Navas, DLRC Regulatory Consulting
Isra Salim, Causaly
Ajay Karandikar, Omnitheia
04.10 PM – 04.30 PM | Executive Summary of the day
04:30 PM – 08:30 PM | Champagne Evening Reception
Champagne drinks reception and evening keynote designed to build lasting partnerships across the tech, healthcare, and life sciences ecosystem.
We promise that our #CreativeDisruption Forum will be like no other life sciences event or business network you have experienced. You will be walking out of the session inspired, educated and more connected.
ADMISSION FEE for Service Companies such as CROs, CDMOs, Law Firms and Patent Attorneys, Consultancy Firms = £150 - ALL-INCLUSIVE
ADMISSION FEE for Innovative Emerging Life Science Companies and Independent Consultants = £80
Investors can apply for free entry by writing to graham@biosell.co.uk.
Good to know
Highlights
- 11 hours
- In-person
Refund Policy
Location
ARC West London
Manbre Road
London W6 9RH
How do you want to get there?
